Corsair Pharma
PrivateLast Round
Series B
Sep 20, 2023
Total Funding Raised
$23M
Company Overview
Corsair Pharma is a biotechnology company that develops novel prodrugs of treprostinil for the treatment of pulmonary arterial hypertension using a once-daily transdermal patch.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Corsair Pharma Comparables
Compare Corsair Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| United Therapeutics | 74% | |
| Insmed Incorporated | 69% | |
| Gossamer Bio | 68% | |
Corsair Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 20, 2023 | ||||
| Strategic | Jan 3, 2018 |
Key People
Founding team and executive leadership
Corsair Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Midas Capital Management | Series B |
| Junson Capital | Series B |
| New Rhein Healthcare Investors | Series B |
| Plaisance Capital Management | Series B |
| Primavera Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2025
New data on Treprostinil Prodrug Transdermal System to be presented at PHPN 2025.
- Sep 15, 2025
Will present new data at the PHPN 2025 Symposium.
Corsair Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Corsair Pharma's valuation, stock price, and market status.